A cDNA for a novel human papain-like cysteine protease, designated cathepsin F, has been cloned from a gt10-skeletal muscle cDNA library. The nucleotide sequence encoded a polypeptide of 302 amino acids composed of an 88-residue propeptide and a 214-residue mature protein. Protein sequence comparisons revealed 58% homology with cathepsin W; about 42-43% with cathepsins L, K, S, H, and O; and 38% with cathepsin B. Sequence comparisons of the propeptides indicated that cathepsin F and cathepsin W may form a new cathepsin subgroup. Northern blot analysis showed high expression levels in heart, skeletal muscle, brain, testis, and ovary; moderate levels in prostate, placenta, liver, and colon; and no detectable expression in peripheral leukocytes and thymus. The precursor polypeptide of human recombinant cathepsin F, produced in Pichia pastoris, was processed to its active mature form autocatalytically or by incubation with pepsin. Mature cathepsin F was highly active with comparable specific activities toward synthetic substrates as reported for cathepsin L. The protease had a broad pH optimum between 5.2 and 6.8. Similar to cathepsin L, its pH stability at cytosolic pH (7.2) was short, with a half-life of approximately 2 min. This may suggest a function in an acidic cellular compartment. Transient expression of T7-tagged cathepsin F in COS-7 cells revealed a vesicular distribution of the gene product in the juxtanuclear region of the cells. However, contrary to all known cathepsins, the open reading frame of the cathepsin F cDNA did not encode a signal sequence, thus suggesting that the protease is targeted to the lysosomal compartment via an N-terminal signal peptide-independent lysosomal targeting pathway.
pressed, intracellular housekeeping proteases responsible for the general lysosomal protein breakdown. The cathepsins L, B, H, and probably O (1, 2) belong to this group. The other group is characterized by a tissue restricted expression pattern and by the assignment of specific functions correlated with their tissue distribution. For example, cathepsin S, the first known tissue-specific cysteine protease is primarily expressed in lymphatic tissues (3, 4) and is responsible for the specific degradation of the invariant chain of MHC class II complexes in antigenpresenting cells (5, 6) . Cathepsin K, which is predominantly expressed in osteoclasts, is a major protease in bone resorption (7) (8) (9) , and, recently, cathepsin W as a cytotoxic lymphocytespecific protease has been reported (10) .
All presently known thiol-dependent cathepsins share common protein structures with a signal sequence of 16 -18 amino acids, followed by a propeptide of 62-100 residues and then a catalytically active mature region of about 220 -230 amino acids (1) . The signal sequence, containing stretches of hydrophobic amino acids, facilitates the targeting of these proteins into secretory pathways via the endoplasmic reticulum (11) . The propart is involved in the folding of the precursor protein, in the temporary inhibition of the protease in its precursor form, and in transport of the proenzyme to the endosomal/ lysosomal compartment using mannose 6-phosphate N-glycosylation sites (12, 13) . Finally, the mature, catalytically active, enzyme contains the catalytic triad consisting of Cys-25, His-159, and Asn-175 (papain numbering) and is folded into a two-domain structure (14) . In addition, thiol-dependent cathepsins have been characterized as lysosomal enzymes, since they have signal sequences and potential N-glycosylation sites and generally have pH optima in the acidic pH range.
In this report, we describe a newly identified member of the papain family, designated cathepsin F, which is ubiquitously expressed in human tissues but which in contrast to the known cathepsins (L, B, S, H, K, and W) lacks a signal sequence.
EXPERIMENTAL PROCEDURES
Cloning of Human Cathepsin F cDNA-In an effort to identify novel cysteine proteases, degenerate oligonucleotides, designed to regions around the characteristic active site residues for cysteine proteases, C-25 and N-175 (sense primer, 5Ј-tg(t/c) tgg gct tt(t/c) ag(t/c)-3Ј; antisense primer, 5Ј-(c/t/a/g)cc cca gct gtt (c/t)tt-3Ј) were used to amplify cDNAs from alveolar lung macrophage transcribed mRNAs (15) . The resulting PCR 1 products (approximately 500 bp) were subcloned into the vector pCR ® II (Invitrogen, San Diego, CA). 150 colonies were con-firmed for insert with EcoRI digestion and grouped with diagnostic digestion using HinfI and DdeI, respectively. 30 colonies were selected for DNA sequence analysis based on the diagnostic digestions. In addition to cathepsins S, K, L, and H, one novel sequence containing 323 bp was found based on the alignment with other known cysteine proteases. DNA sequence analysis demonstrated that this novel sequence contained the original antisense primer sequence but not the sense primer. The 323-bp fragment was amplified and cloned into the vector pCR ® II (Invitrogen) and labeled with [␣- 32 P]dCTP (300 Ci/mmol; NEN Life Science Products) using a random prime DNA labeling system (Boehringer Mannheim). The labeled insert was used to screen 700,000 clones of a gt10 skeletal muscle cDNA library (1.5 ϫ 10 6 independent clones; CLONTECH, Palo Alto, CA) as described (16) , and four positive clones were isolated. Purified phage DNA was isolated using the Trap Plus system (CLONTECH), and cDNA inserts were cloned into the EcoRI site of plasmid pBluescript SKIIϩ phagemid (Stratagene, La Jolla, CA). The cDNA clones isolated were not full-length and encoded overlapping regions of the mature protein. To isolate 5Ј sequences encoding the proregion of cathepsin F, two gene-specific oligonucleotides were designed that allowed the 5Ј rapid amplification of cDNA ends (RACE) to be performed (antisense for 5Ј-RACE, 5Ј-tag tca tcc tct gtc tcc agc-3Ј and 5Ј-att gcc tgt gac tga gaa ggc-3Ј). These primers were used with Marathon-Ready lung cDNA (CLONTECH) in conjunction with the Advantage KlenTag polymerase kit as described in the user's manual (CLON-TECH). Distinct 400 -600-bp bands were gel-purified and cloned using the TA cloning system. DNA sequencing revealed that the fragments encoded the 5Ј part of the cathepsin F gene including two putative start codons. The cDNA encoding the open reading frame starting with Met-1 (starting at nucleotide sequence position 321) and ending at the TGA stop codon was amplified by PCR from a gt10 skeletal muscle cDNA library (CLONTECH) using Pfu polymerase and the following oligonucleotide primers (sense, 5Ј-cg gaattc atg att tct tct ctg tcc caa aac-3Ј containing an EcoRI site; antisense 5Ј-aa gcggccgc tca gtc cac cac cgc cga gct ggc-3Ј containing a NotI site). The PCR product was ligated into the vector pCR-ScriptAmp SK(ϩ) (Stratagene, La Jolla, CA). The insert of the resulting vector, pCTSF1, was subsequently verified by sequencing.
Primer Extension-To determine the transcription start site, 20 g of total RNA from human brain, human lung, and human vascular smooth muscle cells, respectively, were isolated as described previously (17) , and mixed with 0.25 g of [␥-P 32 ]dATP-labeled oligonucleotide (5Ј-cc ata ctg agc tgt gcc acg-3Ј). Mixtures were dried, and 50 l of buffer containing 1.5 M KCl, 0.1 M Tris, pH 8.3, 100 mM EDTA was added into each sample and denatured at 65°C for 90 min. Denatured RNA-primer mixtures were ethanol-precipitated and 13 l of distilled H 2 O, 5 l of reverse transcription buffer (Promega, Madison, WI), 2.5 l of 10 mM dNTP (Life Technologies, Inc.), 1.5 l of bovine serum albumin (Promega), and 2 l of Moloney murine leukemia virus (Life Technologies, Inc.) were added and incubated for 90 min at 42°C followed by incubation with 1 l of 0.5 M EDTA and 1 l of RNase A (10 mg/ml) at 37°C for 30 min. Reaction mixtures were phenol/chloroform-extracted and ethanol-precipitated, and then samples were dissolved into 10 l of DNA sample buffer. 3-l aliquots of each reaction mixture were separated on a 6% DNA sequencing gel, and the dried gel was exposed to X-Omat film (Eastman Kodak Co.).
Northern Blot Analysis-An [␣-32 P]dCTP-labeled 300-bp fragment of cathepsin F was prepared as described above and used to probe multiple tissue Northern blots containing mRNAs from various tissues (CLON-TECH). The blots were washed in 2ϫ SSC, 0.05% SDS for 60 min at room temperature and for 60 min at 65°C in 0.1ϫ SSC, 0.1% SDS. As control DNA, a radioactive labeled actin probe (CLONTECH) was used.
Construction of a Transfer Vector and Expression in Pichia pastorisThe coding region of cathepsin F was excised from the vector pCTSF1 with EcoRI and NotI, ligated into the EcoRI and NotI sites of the multicloning site of the pPIC-9 expression vector (Invitrogen), and subsequently linearized with BglII and electroporated into P. pastoris GS115 host cells using standard procedures (Invitrogen, San Diego, CA). Using the EcoRI site in the multicloning site of pPIC-9 for the 5Ј-end insertion of cathepsin F results in a fusion protein between the S. cerevisiae ␣-mating factor prepropeptide and full-length cathepsin F with an additional insertion of the tripeptide Tyr-Val-Glu derived from the multicloning site (instruction manual for the pPIC-9 vector, Invitrogen, San Diego, CA). His ϩ Mut S clones that produced recombinant human cathepsin F were selected and tested for productivity. A P. pastoris clone that was expressing a high level of cathepsin F activity was selected for fermentation as described by Invitrogen. After centrifugation of the fermentor harvest, the clear supernatant was concentrated (60-fold) and diafiltered on a YM10 membrane (Amicon) with 50 mM sodium acetate, 2.5 mM EDTA, 2.5 mM dithiothreitol, pH 5.5.
Construction of a pcDNA3.1-based Expression Vector for Cathepsin F and Expression in COS-7 Cells-
The cDNA encoding the open reading frame of cathepsin F starting with Met-2 was amplified by PCR using pCTSF1 as template, Pfu polymerase (Stratagene, La Jolla, CA), and the following oligonucleotide primers: sense, 5Ј-cct aag ctt tca gcc atg att tct tct ctg tcc caa aac c-3Ј containing a HindIII site; antisense containing a T7 Tag (underlined) and a XbaI site, 5Ј-aa tct aga gct cat ccc atc tgc tgt cct cca gtc ata ctg gcc atg tcc acc acc gcc gag ctg g-3Ј. The obtained PCR product was digested with XbaI and HindIII, gel-purified using GeneClean (Bio 101, Inc., Vista, CA), and subcloned into the expression vector pcDNA 3.1 (Invitrogen, Carlsbad, CA). The insert and the flanking regions of the resulting vector, pcDNA 3.1 CF-T7, were sequenced in both directions.
Green monkey COS-7 cells were maintained in Dulbucco's modified Eagle's medium supplemented with 20 mM glutamine, 100 units of penicillin, 100 units of streptomycin (all from Fisher), and 10% heatinactivated fetal bovine serum (Gemini Bio-Products, Calabasas, CA) at 37°C in a humidified 5% CO 2 atmosphere. Cathepsin F was transiently expressed in the COS cells using Lipofectamine TM (Life Technologies, Inc.). Cells were harvested at 50 -70% confluency from flasks by EDTA/ trypsin (Sigma), washed twice with PBS (pH 7.4), seeded directly onto sterilized three-field slides (BioGenex, San Ramon, CA), and cultured for 12-15 h. The slides showing approximately 50% confluence were used for transient transfection, which was carried out according to the manufacturer's protocol. Briefly, slides were washed twice in PBS and once in DMEM without any supplements. One g of plasmid DNA from a midikit preparation (Qiagen, Hilden, Germany) was resuspended in 100 l of DMEM and mixed with 6 l of Lipofectamine (which was earlier resolved in 100 l of DMEM), and the mixture were incubated at room temperature for 30 -40 min. After complex formation, 800 l of DMEM were added, and cells were covered with 100 -200 l of transfection mixture/field. Cells were incubated in the CO 2 incubator for 5-6 h, and then 700 l of complete DMEM/field were added. After overnight culture, the medium was replaced, and finally cells were cultured for 48 h.
Slides with pcDNA3.1CF-T7 transiently transfected COS-7 cells were washed twice with PBS (pH 7.4), and cells were fixed with fresh 4% TBS (w/v) containing 0.02% Tween 20 (Fisher) for 10 min. After three extensive washes, TBS/Tween cells were directly used for staining or subsequently dehydrated in ethanol (25, 50, 75 , and 100% each at 15 min) and stored at Ϫ20°C until use.
After blocking cells using goat serum in PBS (BioGenex) at room temperature for 45 min, cells were rinsed twice with TBS/Tween and then incubated with the anti-T7 monoclonal antibody (Novagen, Madison, MI) overnight. After washing the cells with TBS containing 0.02% Tween 20 (3 ϫ 20 min), the cells were treated with anti-mouse IgGtetramethyl rhodamine isothiocyanate (TRITC; both from Sigma) as recommended by the manufacturer. After washing the cells with TBS/ Tween, the cells were mounted using Fluoromount-G TM (Southern Biotechnology Association Inc., Birmingham, AL) and viewed with a fluorescence microscope (Eclipse-E-800, Nikon). As control, COS-7 cells were stained with acridine orange to localize the acidic (lysosomal) compartments of the cells. COS-7 cells were seeded on three chamber slides (1 ϫ 10 4 cells/ml) and grown overnight in DMEM. The cells were incubated with acridine orange (Sigma) at a final concentration of 20 M in DMEM for 15 min at 37°C and finally washed in 1ϫ PBS. After the washing, live cells were immediately viewed with the fluorescence microscope.
Activation and Purification-The concentrated P. pastoris culture supernatant containing recombinant procathepsin F was adjusted to pH 4.5 using 3 M sodium acetate, pH 4.0, supplemented with dithiothreitol (final concentration 0.5 mM) and 0.4 mg/ml porcine pepsin (Sigma). The activation mixture was incubated in a shaker for 5 h at 37°C and 200 rpm. The activation was monitored using Z-Phe-Arg-MCA as a fluorogenic substrate in 100 mM sodium acetate buffer, pH 5.5, containing 2.5 mM EDTA-Na 2 and 2.5 mM dithiothreitol. The activated supernatant was cleared again by centrifugation, loaded on a HiTrap SP column (Amersham Pharmacia Biotech), and eluted with a 0 -1 M NaCl gradient in 20 mM sodium acetate, pH 5.5, containing 1 mM dithiothreitol and 1 mM EDTA. Active cathepsin F was eluted between 0.2 and 0.3 M NaCl.
To compare the autocatalytic pH-dependent activation of procathepsin F with that of pepsin-mediated activation, unpurified recombinant precursor was incubated at pH 4.2, pH 5.0 (10 mM sodium acetate buffer, 2.5 mM EDTA/dithiothreitol), and pH 6.0 (100 mM potassium phosphate buffer, 2.5 mM EDTA/dithiothreitol) in the absence or presence of 0.4 mg/ml porcine pepsin (Sigma). The activation mixture was incubated in a shaker at 37°C and 200 rpm. At appropriate time intervals, aliquots were withdrawn, and the activation of the protease was monitored as described above and by Western blot analyses.
Western Analyses-A polyclonal antibody (MS25) against the human cathepsin F peptide, GHMQSANFSAEK, was raised in rabbits and purified on a Protein A column (Pierce). For Western analyses, an antibody dilution of 1:10,000 was used, and signals were detected using POD-labeled anti-rabbit IgG and the ECL™ substrate (Amersham Pharmacia Biotech). In order to determine N-linked glycosylation of recombinant cathepsin F, unpurified precursor protein from the culture medium supernatant was incubated for 1 h at pH 5.5 with endoglycosidases F and H (Boehringer Mannheim) as recommended by the manufacturer.
Cathepsin F Assays with Methylcoumarylamide Substrates-Initial rates of substrate hydrolysis were monitored in 1-cm cuvettes at 25°C in a Perkin-Elmer fluorimeter at excitation and emission wavelengths of 380 and 450 nm, respectively. Recombinant human cathepsin F was assayed at a constant enzyme concentration (1-18 nM) in 50 mM potassium phosphate buffer, pH 6.5, containing 2.5 mM dithioerythritol and 2.5 mM-Na 2 EDTA and variable substrate concentrations. Fluorogenic substrates, Z-FR-MCA and Z-RR-MCA, were purchased from Bachem International (Bubendorf, Switzerland); Z-LR-MCA and Z-VR-MCA were synthesized as described using standard procedures in peptide chemistry (18) . The kinetic constants, V max and K m , were obtained by nonlinear regression analysis using the program Enzfitter (19) . The active site concentration of cathepsin F was determined with morpholine urea-Leu-homophenylalanine-vinyl sulfone-Ph using the method described for E-64 as active site titrant (20). Morpholine urea-Leuhomophenylalanine-vinyl sulfone-Ph is a potent and irreversible inhibitor of cysteine proteases (21) (kindly provided by J. T. Palmer (Axys Pharmaceutical, South San Francisco, CA).
pH Activity Profile and pH Stability-Initial rates of substrate hydrolysis were monitored as described above. The pH activity profile of human cathepsin F was obtained at 1 M substrate (Z-FR-MCA) concentration ([S] Ͻ K m , where the initial rate, v o , is directly proportional to the k cat /K m value). The following buffers were used for the pH activity profile: 100 mM sodium citrate (pH 2.8 -5.6) and 100 mM sodium phosphate (pH 5.8 -8.0). All buffers contained 1 mM EDTA and 0.4 M NaCl to minimize the variation in ionic strength. A three-protonation model (22) was used for least square regression analysis of the pH activity data. The data were fitted to the following equation.
The pH stabilities of active cathepsins F and L were determined in 100 mM sodium acetate buffer, pH 5.0 (lysosomal pH) and in potassium phosphate buffer, 7.2 (cytosolic pH). At appropriate time intervals, aliquots of the incubation mixture were withdrawn, and the activity was measured using the fluorogenic substrate assay described above.
RESULTS AND DISCUSSION
Human Cathepsin F cDNA-A novel 323-bp PCR fragment was obtained from a human alveolar lung macrophage library using degenerate primers derived from regions surrounding the conserved active site residues, cysteine and asparagine, of the papain superfamiliy (23) . The PCR fragment displayed several motifs typical for papain-like cysteine proteases; however, it was not identical to the sequences of human cathepsins B, L, H, S, K, C, O, and W. Using this fragment, approximately 700,000 clones of a gt10 skeletal muscle cDNA library were screened, and four positive clones were isolated. Since all four clones were incomplete at the 5Ј-end of the coding region, the missing 5Ј-end was obtained using the 5Ј-RACE cloning system and specific primers obtained from the initial 323-bp fragment and the incomplete clones. The complete 3Ј-untranslated end, including the polyadenine tail, was obtained by searching the expressed sequence tag data base using peptide sequences obtained from gt10 skeletal muscle clones. An expressed sequence tag clone (AA564691) was identified to contain the 3Ј-untranslated region of the protease. In addition, several expressed sequence tag clones (AI042401, H15749, and H40022) were identified to contain additional 5Ј sequences (nucleotides 1-118) . Since the nucleotide and the derived protein sequence clearly represented a novel putative papain-like cathepsin, we assigned the name cathepsin F 2 to the gene and its gene product.
Three putative translation initiation codons were identified in the 5Ј region of the isolated cDNA starting at nucleotides 50, 213, and 321. Primer extension experiments using total RNA indicated that the major transcription initiation starts at position 219 with tct tct ctg . . . , thereby eliminating the potential atg start codons at positions 50 and 213 (Fig. 1) . Interestingly, a second minor start site was found upstream of the potential atg start codon at position 119 in mRNA isolated from smooth muscle cells, a site not found in either brain or lung mRNA (Fig. 1) . No start site that would include the potential atg start codon at position 50 was identified. In contrast to related lysosomal cysteine proteases like cathepsins L, K, S, and H, the Met-1 in cathepsin F is not succeeded by a typical hydrophobic signal sequence (25) (neither were the methionines coded by atg codons beginning at nucleotides 50 and 213). Since cathepsin F is missing a signal sequence, it is unlikely that the protease is able to enter the endoplasmic reticulum via the SRP-dependent route and may not be targeted to lysosomes. In addition, neither an endoplasmic reticulum retention signal sequence (26, 27) nor peptide sequences for targeting cytosolic proteins to lysosomes (28) have been identified in the open reading frame of cathepsin F. Studies to determine the intracellular localization of cathepsin F are presently in progress.
Based on these studies, full-length cDNA of human cathepsin F encodes a 302-amino acid protein (Fig. 2) with a calculated molecular mass of 33,860 Da. The open reading frame starts after a typical translation initiation sequence (Ϫ3, A (29)) at nucleotide 321 with an atg codon. A guanidine residue present in the ϩ4-position in the cathepsin F cDNA sequence has also been described to be optimal for the binding of ribo- 2 It should be noted that the name cathepsin F was previously assigned to a 50 -70-kDa proteoglycan-degrading activity (24) . However, this cathepsin F activity was characterized neither on a gene nor on a protein level, and it is unrelated to the protease described in this report. somes (29) . None of the two other putative translation start sites have both of these residues in positions Ϫ3 and ϩ4. The open reading frame ends at nucleotide 1269 with a tga stop codon followed by a consensus polyadenylation site (aataaa) beginning at nucleotide 1555. The open reading frame of cathepsin F had a propeptide and a mature region containing the conserved putative active site residues, Cys shown to form disulfide bridges in cathepsin K (31) . Therefore, the overall fold of cathepsin F may be similar to cathepsin K. An arrowhead in Fig. 2 marks the putative cleavage site, Leu 88 -Ala 89 , between the proregion and the mature region of the protease. Typically for cathepsins, the second amino acid residue adjacent to the processing site is a proline.
To date, eight human cathepsins of the papain family have been cloned and sequenced (cathepsins B, L, H, S, K, C, O, and W). Multiple sequence alignments of the full-length precursor cathepsins clearly demonstrate that cathepsin F is a new member of this protease family (Fig. 3) . Cathepsin F shares a relatively low degree of protein sequence identity with other cysteine proteases, at best being 42% (58% homology) identical with cathepsin W and only 22% (37.8% homology) identical with cathepsin B (Table I papain-like cysteine proteases are less conserved than their catalytic domains, Karrer et al. (32) identified a motif that distinguished two subfamilies, cathepsin B-and cathepsin Llike proteases. The majority of papain-like cysteine proteases possess the so-called ER(F/W)NIN motif and belong to the cathepsin-L-like enzymes. In contrast, cathepsin F and the recently identified cathepsin W (10) appear to form a third subgroup with the motif ERFNAQ (double underlined in Fig.  2 ), which may have diverged from the cathepsin-L-like subfamily. The putative propeptides of cathepsins F and W share approximately 41% protein sequence identity (54.5% homology), whereas the propeptides of all other cathepsins share only 11-27% sequence identity (27-42% homology) (Table I) . In contrast to cathepsin F, cathepsin W had an N-terminal hydrophobic sequence that was typical for signal sequences.
Tissue Distribution of Cathepsin F-Human cathepsin F expression, detected as a single transcript on Northern blot analysis, was high to moderate in most of the tested tissues and organs (Fig. 4) . High levels of expression were observed in heart, brain, skeletal muscle, testis, and ovary; moderate levels were expressed in kidney, pancreas, placenta, liver, and colon; and low levels were observed in lung, spleen, and small intestine. In addition to the major transcript, very low levels of expression of a 100 -200-base pair larger transcript were ob- TM and SwissProt data base (human cathepsin W precursor, accession no. AF055903; human cathepsin H precursor, accession no. P09668; human cathepsin K (O2) precursor, accession no. S79895; human cathepsin L precursor, accession no. P07711; human cathepsin O precursor, accession no. P43234; human cathepsin S precursor, accession no. P25774; human cathepsin B precursor, accession no. P07858), and the multiple alignment was performed using the Clustal W multiple sequence alignment of MacVector (Oxford Molecular Group, PLC). Identical amino acid residues are darkly shaded, similar amino acids are lightly shaded, and unrelated residue have a white background. served in pancreas, testis, ovary, HeLaS3, and G-361 cells. This is in accordance with the observation of a minor transcription start site in selected tissues (Fig. 1) . Thymus and peripheral leukocytes did not reveal detectable levels of expression. Of note was the high level of expression in brain, which has been not observed for other cathepsins. In addition, Northern analysis of a variety of tumor cell lines revealed high levels of cathepsin F expression in HeLa cells as well as melanoma G-361 and A549 cells. Low level expression was observed in K562 cells, whereas the expression of cathepsin F in various leukemic and lymphoblastic cell lines was below the detection level (Fig. 4) . The ubiquitous expression of cathepsin F is similar to those of cathepsins B, L, and H but is in contrast to the tissue-specific expression of cathepsins S, K, and W.
Expression of Cathepsin F in COS-7 Cells-T7-tagged human cathepsin F was detected by immunofluorescence in transiently transfected COS-7 cells when expressed from the cytomegalovirus promoter in pcDNA3.1. The cDNA insert of the expression vector contained the first two putative atg start codons of cathepsin F coding for Met-1 and Met-2. Primer extension experiments suggested that cathepsin F beginning with Met-1 is the primary translation product but that an expression of a longer polypeptide beginning with Met-2 is also possible (Figs. 1 and 2) . Immunostaining clearly revealed an expression of cathepsin F in vesicles predominantly present in the juxtanuclear region of the cell (Fig. 5A) . No staining was observed with secondary antibody only or mouse IgG. Treatment of COS-7 cells with acridine orange as marker for acidic compartments revealed a comparable juxtanuclear staining pattern typical for lysosomes (Fig. 5B) . The vesicular, lysosomal-like distribution of the gene product is unexpected for a protein expressed without a signal sequence. Interestingly, the staining pattern of cathepsin F is similar to that observed for a truncated form of cathepsin B, which also is missing its signal sequence and a part of its prodomain (33). Mehtani et al. (33) could demonstrate that truncated cathepsin B is associated with the cytosolic surface of membrane organelles. Whether cathepsin F is located inside the observed vesicles or facing the cytosolic side of vesicular membranes is presently under investigation.
Expression, Activation, and Purification of Recombinant Human Cathepsin F-To generate a functional protease for in . Cells were fixed and stained with anti-T7 monoclonal antibody and anti-mouse IgGtetramethyl rhodamine isothiocyanate as described under "Experimental Procedures." B, COS-7 cells stained with acridine orange.
TABLE I Protein sequence homologies of cathepsin F with the cathepsins L, K, S, B, H, O, and W
The first number reflects sequence identity, and the number in parenthesis shows sequence homology. The sequences were analyzed with the program PCGENE using the Myers and Miller algorithm. vitro studies, human cathepsin F was expressed in yeast using the P. pastoris expression system and the ␣-pheromone signal sequence for extracellular targeting and thus for facilitating protein purification. The expression level of the protease in the culture supernatant following activation with pepsin was monitored by its Z-FR-MCA-hydrolyzing activity inhibitable with 100 M E-64. Wild-type P. pastoris does not produce an endogenous Z-FR-MCA-hydrolyzing activity. The culture supernatant was collected after 3 days of fermentation and was 20-fold concentrated by ultrafiltration. Activation of the inactive precursor was achieved by autoactivation at pH 4.2 or could be accelerated by the addition of pepsin (Fig. 6) . Autoactivation was very weak at pH 5.0 and practically abolished at pH 6.0 (Fig. 6 ). Pepsin-mediated activation had the advantage that it resulted at the same time in the efficient proteolytic removal of most of the contaminating high molecular protein components present in the culture supernatant. Complete activation was achieved after 3 h at 37°C with 0.4 mg/ml porcine pepsin ( -Arg-Thr) (underlined in Fig. 2) . Recombinant propeptides and mature cathepsin F polypeptides, which were produced in yeast using the ␣-pheromone signal peptide for extracellular secretion, were glycosylated and had molecular masses of 44 and 34 kDa, respectively. After treatment with endoglycosidases H and F, the molecular masses decreased to approximately 35 and 29 kDa, respectively. This suggests that both the proregion and the mature protein are N-linked glycosylated and that the glycosylation of the prosite is approximately 4 kDa and that of the mature sites about 5 kDa. It is likely that more than one of the three putative N-glycosylation sites of the mature polypeptide were used. The determined molecular masses for the recombinant cathepsin F polypeptides were in very good accord with those of other recombinant cathepsins such as cathepsins L, K, and S (Fig. 7) . 3 As stated above, recombinant cathepsin F was generated as fusion protein containing the strong yeast ␣-pheromone secretory signal sequence. Thus, the fusion protein was targeted to the secretory pathway, and subsequent N-linked glycosylation occurred. Since human wild-type cathepsin F lacks the signal peptide, translocation into the endoplasmic reticulum via the signal recognition particle route is unlikely, as is the processing of the N-glycosylation sites. No evidence is presently available as to whether these sites are used for in vivo glycosylation. Activated cathepsin F was purified at room temperature on HiTrap SP-Sepharose. Active cathepsin F was eluted as a single peak at a salt concentration of 0.2-0.3 M NaCl using a gradient of 0 -1 M NaCl in 20 mM sodium acetate buffer, pH 5.5. The resulting protein had approximately 80 -90% purity on a SDS-polyacrylamide gel (data not shown) and was used for the physicokinetic characterization of the protease. S 2 P 2 Subsite Specificity of Recombinant Human Cathepsin F-The substrate binding region of proteases is defined as an arrangement of binding pockets or subsites (S) for several peptide substrate amino acid residues (P) contiguous to both sides of the scissile bond. Seven such sites have been described for the plant cysteine protease papain (34) . However, based on x-ray crystallographic studies of papain-like proteases, such as cruzain and cathepsins B, L, and K (31, (35) (36) (37) only the S 2 subsite, which binds the second amino acid residue upstream of the scissile bond, forms a real pocket, whereas the other subsites are more or less shallow enclaves on the surface of the protease. The S 2 binding pocket defines the primary substrate 3 D. Brömme, unpublished data.
FIG. 6. Activation of procathepsin F.
Left, time-dependent activation of human cathepsin F at 37°C in 100 mM sodium acetate buffer, pH 4.2, in 100 mM sodium acetate buffer, pH 5.0, and 100 mM potassium phosphate buffer, pH 6.0, and at pH 4.2 with pepsin (0.4 mg/ml). Aliquots were withdrawn from the preincubation mixture at the indicated time points, and the activity was monitored with 10 M Z-LR-MCA. Right, Western analyses of procathepsin F autocatalytic processing at pH 4.2 and pepsin-mediated processing at pH 4.2. Aliquots of recombinant human procathepsin F containing supernatant of a 3-day P. pastoris culture were incubated with pepsin as described above. The times of digestion are as indicated. Molecular mass standards (kDa) are indicated on the right. Mature cathepsin F and procathepsin F were detected by Western blot analysis using a cathepsin F surface peptide targeted antibody (see "Experimental Procedures").
FIG. 7. Recombinant human cathepsin F is N-glycosylated.
Treatment with endoglycosidases H and F results in a decrease in molecular mass of the proenzyme by approximately 9 kDa and a decrease in mass of the mature enzyme by 5 kDa, indicating that both the proregion and the mature part of recombinant cathepsin F are N-linked glycosylated. The enzyme was activated autocatalytically at pH 4.2 for 48 h. specificity of cathepsins. The S 2 P 2 subsite specificity of cathepsin F was determined with synthetic substrates of the type Z-XF-MCA (where X represents Phe, Leu, Val, or Arg) and compared with the relative activities of cathepsins L, K, B, and S. The specificity of cathepsin F resembled those of cathepsins L, S, and K. All four cathepsins prefer bulky hydrophobic residues (phenylalanine and leucine) over the smaller ␤-branched valine, and a positively charged arginine residue in P 2 results in a very poor substrate hydrolysis. Only cathepsin B was able to efficiently hydrolyze Z-RR-MCA (38) . However, in contrast to cathepsins L, S, and K, which preferred either leucine or phenylalanine in the P 2 position, cathepsin F accepted both residues equally well (Fig. 8) . This may indicate a wide and less restricted S 2 subsite pocket in cathepsin F.
The catalytic efficiency (k cat /K m ) of cathepsin F toward the studied synthetic substrates was high and comparable with that of cathepsin L (Table II) . The high second-order rate constants for both enzymes were mainly due to the submicromolar K m values. It should be noted that cathepsin L is the catalytically most active known lysosomal cysteine protease (1) .
pH Activity Profile and pH Stability-Recombinant human cathepsin F had a pH optimum between 5.2 and 6.8 (90% of maximal activity). The enzyme was characterized by a relatively broad pH activity profile with flanking pK values of 4.5 and 7.2 (Fig. 9) . The descending limb of the profile is incomplete due to the instability of the protease at pH values above pH 7.2. The width of the pH profile (pK 2 Ϫ pK 1 ), which reflects the stability of the ion pair formed by the active site residues cysteine and histidine (39), was 2.7 for cathepsin F. This value is 0.6 units smaller than that of the neutral pH-stable cathepsin S (40) . No value for human cathepsin L could be calculated since the instability of the protease at neutral pH did not allow determination of a pK 2 value.
The pH stability of cathepsin F was compared with that of cathepsin L. Considering a potential nonlysosomal localization of cathepsin F, the enzyme's stability was determined at pH 5.0 (lysosomal pH) and pH 7.2 (cytosolic pH). Cathepsins F and L were both stable at pH 5.0 for 4 h but both very unstable at neutral pH. However, cathepsin F exhibited a slightly higher pH stability at pH 7.2 with short incubation times. Whereas lysosomal cathepsin L had a half life of less than 1 min at pH 7.2 and 37°C, the half-life of cathepsin F was more than twice as long (2.2 min). Compared with previously described cytosolic cysteine proteases such as the calpains (41) and bleomycin hydrolase (42) , cathepsin F activity at neutral pH was very short lived. The determination of the enzyme's precise subcellular localization will shed light on the contradiction between a possible nonlysosomal localization (suggested by the lack of the signal peptide) and the low pH stability of the protease at cytosolic pH.
In conclusion, human cathepsin F is a new member of the papain-protease family that is ubiquitously expressed in most tissues. Multiple sequence alignments indicate that cathepsin F belongs with cathepsin W to a new cathepsin subgroup. Contrary to all other related cysteine proteases, cathepsin F does not possess a signal sequence, which suggests either a nonlysosomal subcellular localization or an alternative mechanism for targeting to the lysosome. Its catalytic efficiency toward synthetic peptide substrates is comparable with cathepsin L, with a primary substrate specificity similar to that of cathepsins L, S, and K. The widespread tissue distribution and high catalytic activity may indicate a housekeeping function of cathepsin F essential in most cells. In addition, cathepsin F must be considered as a novel antitarget for drug discovery efforts directed against cysteine proteases such as cathepsins K, B, L, and S.
